A fat-regulating enzyme could hold the key to obesity, diabetes, cancer, other diseases

It had already been known that the enzyme known as phosphatidic acid phosphatase plays a crucial role in regulating the amount of fat in the human body. Controlling it is therefore of interest in the fight against obesity. But scientists have now found that getting rid of the enzyme entirely can increase the risk of cancer, inflammation and other ills.

Heart hormones protect against obesity and insulin resistance

By fleshing out how one signaling receptor contributes to causing obesity through its activity in fatty tissue but not in muscle cells, scientists have zeroed in on an important new avenue of exploration for combating metabolic disease. More than one-third of American adults are considered to be obese, which dramatically increases their risk for developing type 2 diabetes, non-alcoholic fatty liver disease, high blood pressure, and multiple inflammatory conditions.